Lista de obras - Fernanda Andrade Orsi - Dominio Público Uruguay

A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection

artículo científico publicado en 2009

Acquired thrombotic thrombocytopenic purpura due to antibody-mediated ADAMTS13 deficiency precipitated by a localized Castleman's disease: a case report

artículo científico publicado en 2014

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk

artículo científico publicado en 2019

Bleeding complications in dengue are not associated with significant changes in the modulators of the endothelial barrier

artículo científico publicado en 2014

Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome

scientific article published on 25 September 2018

Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies

artículo científico publicado en 2019

Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies: Author´s reply

artículo científico publicado en 2020

Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.

artículo científico publicado en 2016

Diagnosis of Scott syndrome in patient with bleeding disorder of unknown cause.

artículo científico publicado en 2012

Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.

artículo científico publicado en 2008

Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias.

artículo científico publicado en 2017

Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020

artículo científico publicado en 2020

Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome

artículo científico publicado en 2020

Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism.

artículo científico publicado en 2015

Home management of INR in the public health system: feasibility of self-management of oral anticoagulation and long-term performance of individual POC devices in determining INR.

artículo científico publicado en 2016

Increased ADAMTS13 activity in patients with venous thromboembolism

artículo científico publicado en 2012

Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels

artículo científico publicado en 2014

Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome

artículo científico publicado en 2020

Laboratory evaluation of patients with undiagnosed bleeding disorders

artículo científico publicado en 2016

Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis

scientific article published on 31 December 2014

Long-term prospective study of recurrent venous thromboembolism in a Hispanic population

artículo científico publicado en 2010

Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden.

artículo científico publicado en 2009

Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic

artículo científico publicado en 2012

Performance of a point-of-care device in determining prothrombin time in supra-therapeutic INRs.

artículo científico publicado en 2012

Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis

artículo científico publicado en 2010

Prevalence of Factor IX-R338L (Factor IX Padua) in a cohort of patients with venous thromboembolism and mild elevation of factor IX levels

artículo científico publicado en 2010

Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response

article

Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case-control study comparing dengue fever patients with and without bleeding manifestations

artículo científico publicado en 2013

Residual Vein Thrombosis Echogenicity Is Associated to the Risk of DVT Recurrence: A Cohort Study.

artículo científico publicado en 2017

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

artículo científico publicado en 2019

Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation

artículo científico publicado en 2014

Severe postthrombotic syndrome is associated with characteristic sonographic pattern of the residual thrombosis

artículo científico publicado en 2016

VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.

artículo científico publicado en 2010

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database

artículo científico publicado en 2022

Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus

artículo científico publicado en 2015

Lista de obras de Fernanda Andrade Orsi

A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection

Acquired thrombotic thrombocytopenic purpura due to antibody-mediated ADAMTS13 deficiency precipitated by a localized Castleman's disease: a case report

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk

Bleeding complications in dengue are not associated with significant changes in the modulators of the endothelial barrier

Circulating levels of tissue factor and the risk of thrombosis associated with antiphospholipid syndrome

Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies

Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies: Author´s reply

Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.

Diagnosis of Scott syndrome in patient with bleeding disorder of unknown cause.

Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.

Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias.

Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020

Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome

Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism.

Home management of INR in the public health system: feasibility of self-management of oral anticoagulation and long-term performance of individual POC devices in determining INR.

Increased ADAMTS13 activity in patients with venous thromboembolism

Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels

Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome

Laboratory evaluation of patients with undiagnosed bleeding disorders

Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis

Long-term prospective study of recurrent venous thromboembolism in a Hispanic population

Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden.

Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic

Performance of a point-of-care device in determining prothrombin time in supra-therapeutic INRs.

Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis

Prevalence of Factor IX-R338L (Factor IX Padua) in a cohort of patients with venous thromboembolism and mild elevation of factor IX levels

Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response

Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case-control study comparing dengue fever patients with and without bleeding manifestations

Residual Vein Thrombosis Echogenicity Is Associated to the Risk of DVT Recurrence: A Cohort Study.

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation

Severe postthrombotic syndrome is associated with characteristic sonographic pattern of the residual thrombosis

VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database

Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus